Navigation Links
Contract Services for Big Pharma and Biotechs Driving Growth and Innovation from Discovery to Clinical Trials
Date:2/6/2008

NEW YORK, Feb. 6 /PRNewswire/ -- Over the past few years, the strategic importance of the global pharmaceutical marketplace has become increasingly apparent. Multinational interest and investment in the global pharmaceutical industry is at an all-time high and competition is heating up. On one hand big pharma is pumping in more resources into outsourcing and offshoring. On the other hand, drug safety issues, threat from biogenerics, stricter protocols for APIs and pharmacovigilance issues question some existing models and frameworks. More than ever, as the demand intensifies to fill the pharmaceutical pipeline with new drugs and therapeutics -- outsourcing partnerships are playing an increasingly critical role.

The 2008 BioPharma Outsourcing: Partnerships with CROs and Other Service Providers forum, scheduled for March 25-26, 2008 at the Hilton Boston Back Bay in Boston, MA is designed to bring together pharma and biotech executives from around the world to gather strategic information and creating networking relationships all eager to facilitate new investments and partnerships.
Distinguished Speaker Roster Includes (updated as of February 6, 2008):

-- Diana M. Galer Ph.D., VP, Strategic Management Group, Pfizer Global

Research & Development

-- Mark Tracy, Senior Director, Pharmaceutical Operations, Alnylam

Pharmaceuticals

-- RoseAnn Price, Alliance Management, Amgen

-- Mel Sorensen, M.D., President & CEO, Ascenta Therapeutics, Inc.

-- Ahsan Awan, JD, MBA, CRCP, Global CINRG, Inc.

-- Gur Roshwalb, MD, VP & Senior Analyst Health Care, Piper Jaffray

& Co.

-- Han Gunn, Preclinical Director, Department of Pharmacokinetics & Drug

Metabolism, Amgen

-- Partha S. Ray, MD, CEO, IndusPharma Consulting Group

-- Michael Palladino, PhD, Senior VP, CTO, & Scientific Co-Founder,

Nereus Pharmaceuticals

-- Steve J. Bannister, PhD, Chief Scientific Officer, Xcelience, LLC

-- Judd Berman, PhD., Chief Scientific Officer, Dalton Medicinal

Chemistry

-- Zhengming (Jimmy) Chen, PhD, Senior Director, Chemistry and CMC,

DOV Pharmaceutical, Inc.

-- John Lemelan, General Partner, Riverside Partners

-- Dean Wilson, PhD, Research Fellow, Vertex Pharmaceuticals

-- John Maclennan, PhD, Director, Business Development, Wolfe

Laboratories, Inc.

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0803

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vestibular Technologies Is Awarded Contract by Major Group Purchasing Organization (GPO)
2. DNA is blueprint, contractor and construction worker for new structures
3. Clinimetrics Celebrates 20th Anniversary in Contract Research Business
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
6. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
7. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
8. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
9. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
10. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
11. ICx Awarded Department of Defense Contract for AirSentinel Monitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Summit for Stem Cell has ... development of a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The ... Jeanne Loring at The Scripps Research Institute in San Diego, CA. , ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... support for Connecticut's innovative, growing companies, today announced the launch of VentureClash ... technology (fintech) companies. , “VentureClash looks to attract the best early-stage ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... testing technology at the Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance ... solvents, heavy metals, and more. Expo attendees can stop by booth 1021 to ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of ... appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from ... founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
Breaking Biology Technology:
(Date:3/14/2016)... March 14, 2016 NXTD ) ("NXT-ID" ... commerce market, announces the airing of a new series of ... week of March 21 st .  The commercials will air ... popular Squawk on the Street show. --> NXTD ... growing mobile commerce market, announces the airing of a new ...
(Date:3/11/2016)... 11, 2016 --> ... report "Image Recognition Market by Technology (Pattern Recognition), by ... by Deployment Type (On-Premises and Cloud), by Industry Vertical ... by MarketsandMarkets, the global market is expected to grow ... Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
Breaking Biology News(10 mins):